EXHIBIT 31.2

                            CERTIFICATION PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Randy Moseley, certify that:

1.   I have reviewed this report on Form 10-K of CytoGenix, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material  fact or omit to state a  material  fact  necessary  to make the
     statements made, in light of the circumstances  under which such statements
     were made,  not  misleading  with  respect  to the  period  covered by this
     report;

3.   Based on my  knowledge,  the  financial  statements,  and  other  financial
     information  included  in  this  report,  fairly  present  in all  material
     respects the financial  condition,  results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   The  registrant's  other  certifying  officers  and I are  responsible  for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules  13a-15(e) and 15d-15(e))  and internal  control over
     financial  reporting  (as  defined  in  Exchange  Act Rules  12a-15(f)  and
     15d-15(f) for the registrant and have:

a)   Designed such disclosure controls and procedures, or caused such disclosure
     controls and  procedures to be designed  under our  supervision,  to ensure
     that  material  information  relating  to  the  registrant,  including  its
     consolidated  subsidiaries,  is made  known to us by  others  within  those
     entities,  particularly  during the  period in which  this  report is being
     prepared;

b)   Design such  internal  control  over  financial  reporting,  or caused such
     internal  control  over  financial  reporting  to  be  designed  under  our
     supervision,  to provide reasonable  assurance regarding the reliability of
     financial reporting and the preparation of financial statement for external
     purposes in accordance with generally accepted accounting principles.

c)   Evaluated the  effectiveness  of the registrant's  disclosure  controls and
     procedures  and presented in this annual report our  conclusions  about the
     effectiveness of the disclosure  controls and procedures,  as of the period
     covered by this report based on such evaluations; and

d)   Disclosed in this report any change in the  registrant's  internal  control
     over financial  reporting that occurred during the registrant's most recent
     fiscal (the  registrant's  fourth  fiscal  quarter in the case of an annual
     report) that has materially  affected,  or is reasonably likely affect, the
     registrant's internal control over financial reporting: and

5.   The registrant's other certifying  officers and I have disclosed,  based on
     our most recent evaluation of internal  controls over financial  reporting,
     to the registrant's  auditors and the audit committee of registrant's board
     of directors (or persons performing the equivalent function):

a)   all  significant  deficiencies  and  material  weaknesses  in the design or
     operation  of  internal   controls   which  could   adversely   affect  the
     registrant's  ability to record,  process,  summarize and report  financial
     information;

b)   any fraud,  whether or not  material,  that  involves  management  or other
     employees who have a significant role in the registrant's internal controls
     over financial reporting

Date: May 15, 2009
/s/ Randy Moseley
-----------------
RANDY MOSELEY
(PRINCIPAL FINANCIAL OFFICER)